Summary
To assess the efficacy of combination therapy of aprindine (40 mg/day) and verapamil (160 mg/day), transesophageal programmed atrial stimulation was performed on 21 patients with paroxysmal supraventricular tachycardia (including 12 patients with atrioventricular nodal reentrant tachycardia and nine patients with atrioventricular reentrant tachycardia) under four conditions: a) control, b) aprindine alone, c) verapamil alone, and d) aprindine + verapamil. Results: a) Aprindine, verapamil, and aprindine + verapamil prevented paroxysmal supraventricular tachycardia induction in 2/21, 3/21, and 9/21 patients, respectively;b) aprindine + verapamil prolonged the cycle length of paroxysmal supraventricular tachycardia more than aprindine or verapamil alone; c) aprindine, verapamil, and aprindine + verapamil decreased the AV blocking rate by 15, 23, and 35 beats/min, respectively, in comparison with the control state; d) aprindine, verapamil, and aprindine + verapamil prolonged the effective refractory period of atrioventricular conduction system by 20, 34, and 76 msec, respectively, compared with the control state. In conclusion, aprindine + verapamil appear to be more effective than aprindine or verapamil alone in preventing paroxysmal supraventricular tachycardia with nodal reentry, but there was less benefit in those without nodal reentry (Wolff-Parkinson-White group).
Similar content being viewed by others
References
Wu, D, Wyndham, CR, Denes, P, et al. Chronic electrophysiological study in patients with recurrent paroxysmal tachycardia: A new method for developing successful oral antiarrhythmic therapy. In: Kulbertus, HE, ed. reentrant arrhythmias, Baltimore: University Park Press, 1976: 294–311.
Josephson, ME, Seides, SF. Electrophysiologic investigation: General Concepts. In: Clinical cardiac electrophysiology, techniques and interpretations. Philadelphia: Lea & Febiger, 1979:23–59.
Zipes, DP. A consideration of antiarrhythmic therapy. Circulation 1985;72:949–956.
Zipes, DP. Management of cardiac arrhythmias. In: Braunwald, E, ed. Heart Disease: A textbook of cardiovascular medicine. Philadelphia: W.B. Saunders, 1984:648–682.
Gallagher, JJ, Smith, WM, Kerr, CR. Esophageal pacing: A diagnostic and therapeutic tool. Circulation 1982;65:336–341.
Critelli, G, Grassi, G, Perticone, F, et al. Transesophageal pacing for prognostic evaluation of preexcitation syndrome and assessment of protective therapy. Am J Cardiol 1983;51:513–518.
Benson, WD, Dunnigan, A, Benditt, DG, et al. Prediction of digoxin treatment failure in infants with supraventricular tachycardia: Role of transesophageal pacing. Pediatrics 1985;75:288–293.
Blomstrom-Lundqvist, C, Dohnal, M, Hirsch, T, et al. Effect of long term treatment with metoprolol and sotalol on ventricular repolarization measured by use of transesophageal atrial pacing. Br Heart J 1986;55:181–186.
Bellocci, F, Nobile, A, Spampinato, A, et al. Oral propafenon for prevention of primary atrial fibrillation: Predictive value of the response to transesophageal atrial stimulation. J Am Coll Cardiol 1989;13:233.
Hirao, K. Clinical electrophysiologic study on transesophageal atrial pacing: Evaluation of paroxysmal supraventricular tachycardia. Jpn J Electrocardiol 1986;6:581–589.
Brembilla-Perrot, B, Spatz, F, Khaldi, E, et al. Value of esophageal pacing in evaluation of supraventricular tachycardia. Am J Cardiol 1990;65:322–330.
Rinkenberger, EL, Drystowsky, EN, Heger, J, et al. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation 1980;62:996–1010.
Sakurai, M, Yasuda, H, Kato, N, et al. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia. Am Heart J 1983;105:618–628.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hirao, K., Okishige, K., Suzuki, F. et al. Combination therapy with aprindine and verapamil for paroxysmal supraventricular tachycardia as assessed by transesophageal atrial pacing. Cardiovasc Drug Ther 5 (Suppl 4), 819–825 (1991). https://doi.org/10.1007/BF00120830
Issue Date:
DOI: https://doi.org/10.1007/BF00120830